"10.1371_journal.pone.0081208","plos one","2013-11-20T00:00:00Z","Emanuel Raschi; Elisabetta Poluzzi; Brian Godman; Ariola Koci; Ugo Moretti; Marija Kalaba; Marion Bennie; Corrado Barbui; Bjorn Wettermark; Miriam Sturkenboom; Fabrizio De Ponti","Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy; Division of Clinical Pharmacology, Karolinska Institute, Stockholm, Sweden; Strathclyde Institute of Pharmacy and Biomedical Sciences, Strathclyde University, Glasgow, United Kingdom; Clinical Pharmacology Unit, University of Verona, Verona, Italy; Republic Institute for Health Insurance, Belgrade, Serbia; Information Services Division, NHS National Services Scotland, Edinburgh, United Kingdom; WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy; Centre for Pharmacoepidemiology, Karolinska University Hospital, Solna, Stockholm, Sweden; Erasmus University Medical Centre, Rotterdam, The Netherlands","Conceived and designed the experiments: ER EP FDP. Analyzed the data: ER EP AK BG MK. Wrote the manuscript: ER EP BG. Made substantive suggestions for data interpretation, contributed to the discussion, revised and approved the final submitted manuscript: BG AK UM MK MB CB BW MS FDP.","We have the following interests. In the previous 3 years MS has received grants from Eli Lilly, Pfizer and Astra Zeneca. M. Sturkenboom is running the IPCI research group that occasionally performs studies for pharmaceutical companies (including AstraZeneca, Pfizer, Lilly, Boehringer) and has been consultant to Pfizer, Consumer Health, Novartis, Servier, Celgene, and Lundbeck on issues not related to the study. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.","2013","11","Emanuel Raschi","ER",11,TRUE,3,NA,5,3,TRUE,TRUE,FALSE,0,NA,FALSE
